References
- Abir F, Bell R. Assessment and management of the obese patient. Crit Care Med 2004;32:S87–91
- Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among U.S. children, adolescents, and adults, 1999–2002. JAMA 2004;291:2847–50
- Sarwer DB, Allison KC, Gibbons LM, et al. Pregnancy and obesity: a review and agenda for future research. J Womens Health (Larchmt) 2006;15:720–33
- O'Brien PE, Brown WA, Dixon JB. Obesity, weight loss and bariatric surgery. Med J Aust 2005;183:310–4
- Andreasen KR, Andersen ML, Schantz AL. Obesity and pregnancy. Acta Obstet Gynecol Scand 2004;83:1022–9
- Sheiner E, Levy A, Menes TS, et al. Maternal obesity as an independent risk factor for cesearean delivery. Paediatr Perinat Epidemiol 2004;18:196–201
- Gilead R, Yaniv-Salem S, Sergienko R, Sheiner E. Maternal isolated obesity and obstetric complications. J Matern Fetal Neonatal Med 2012;25:2579–82
- Takashima S, Ise H, Zhao P, et al. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 2004;29:73–84
- Lewis EC, Mizrahi M, Toledano M, et al. Alpha1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci USA 2008;105:16236–41
- Lisowska-Myjak B, Pachecka J. Antigenic and functional levels of alpha-1-antitrypsin in serum during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;106:31–5
- Larsson A, Palm M, Hansson LO, et al. Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand 2008;87:1084–8
- Twina G, Sheiner E, Shahaf G, et al. Lower circulation levels and activity of alpha-1 antitrypsin in pregnant women with severe preeclampsia. J Matern Fetal Neonatal Med 2012;12:2667–70
- Kvasnicka J, Bendl J, Zivný J, et al. Changes in hemostasis and fibrinolysis in gestational diabetes. Cas Lek Cesk 1996;135:106–10
- Lisowska-Myjak B, Pachecka J. Antigenic and functional levels of alpha-1-antitrypsin in serum during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;106:31–5
- Yaghmaei M, Hashemi M, Shikhzadeh A, et al. Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus. Diabetes Res Clin Pract 2009;84:201–4
- Hedderson MM, Williams MA, Holt VL, et al. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol 2008;198:409.e1–7
- Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 2010;115:597–604
- Gibson KS, Waters TP, Catalano PM. Maternal weight gain in women who develop gestational diabetes mellitus. Obstet Gynecol 2012;119:560–5
- Carreno CA, Clifton RG, Hauth JC, et al. Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol 2012;119:1227–33
- Oliva K, Barker G, Riley C, et al. The effect of pre-existing maternal obesity on the placental proteome: two-dimensional difference gel electrophoresis coupled with mass spectrometry. J Mol Endocrinol 2012;48:139–49
- Xue GB, Zheng WL, Wang LH, Lu LY. Alpha 1-antitrypsin. A novel biomarker for obesity in humans. Saudi Med J 2013;34:34–9
- Madar T, Shahaf G, Sheiner E, et al. Low levels of circulating alpha-1 antitrypsin are associated with spontaneous abortions. J Matern Fetal Neonatal Med 2013;26:1782–7